Advanced search
Publication Cover
Toxicology Methods Volume 9, 1999 - Issue 1
Journal homepage
16
Views
2
CrossRef citations to date
0
Altmetric
Research Article

PROTECTIVE EFFECT OF ULINASTATIN ON CISPLATIN-INDUCED TOXICITY IN THE KIDNEY EPITHELIAL CELL LINE, LLC-PK1

Masahiro Okuda, Ayako Takashima, Katsuyasu Tsuda, Ken-Ichi Inui Department of Pharmacy, Kyoto University Hospital, Faculty of Medicine, Kyoto University, Kyoto, Japa n
Pages 1-10 | Published online: 30 Sep 2008

  • Astrup T, Nissen U. Urinary trypsin inhibitor (mingin): transformation into a new trypsin inhibitor by acid hydrolysis or by sialidase. Nature. 1964;4942:255-257.
  • Faarvang HJ, Knudsen PJ. Hyaluronidase inhibitor and trypsin inhibitor in preparations from human urine. Proc Soc Exp Biol Med. 1961;108:591-592.
  • Sumi H, Minakata K, Takada Y, Takada A. Trypsin inhibitors in human urine. J Physiol Soc (Jpn). 1977:39:53-58.
  • Jönsson-Berling B-M, Ohlsson K. Distribution and elimination of intravenously injected urinary trypsin inhibitor. Scand J Clin Lab Invest. 1991;51:549-557.
  • Kudo Y, Egashira T, Yamanaka Y. Protective effect of ulinastatin against liver injury caused by ischemia-reperfusion in rats. Jpn J Pharmacol. 1992;60:239-245.
  • Li X-K, Suzuki H, Kimura T, Kawabe A, Uno T, Harada Y. Ulinastatin, a protease inhibitor, attenuates intestinal ischemia/reperfusion injury. Transplant Proc. 1994;26:2423-2425.
  • Ishigami M, Eguchi M, Yabuki S. Beneficial effects of the urinary trypsin inhibitor urinastatin on renal insults induced by gentamicin and mercuric chloride (HgCl2) poisoning. Nephron. 1991:58:300-305.
  • Umeki S.Tsukiyama K, Okimoto N, Soejima R. Urinastatin (kunitz-type proteinase inhibitor) reducing cisplatin nephrotoxicity. Am J Med Sci. 1989;298:221-226.
  • Hull RN, Cherry WR, Weaver GW. The origin and characteristics of a pig kidney cell strain, LLC-PK1. In Vitro(Rockville). 1976;12:670-677.
  • Amsler K,Cook JS. Development of Na+-dependent hexose transport in a cultured cell line of porcine kidney cells. Am J Physiol. 1982;242:C94-C101.
  • Inui K, Saito H, Takano M, Okano T, Kitazawa S, Hori R. Enzyme activities and sodiumdependent active D-glucose transport in apical membrane vesicles isolated from kidney epithelial cell line (LLC-PK1). Biochim Biophys Acta. 1984;769:514-518.
  • Hori R, Yamamoto K, Saito H, Kohno M, Inui K. Effect of aminoglycoside antibiotics on cellular functions of kidney epithelial cell line (LLXD-PK1): a model system for aminoglycoside nephrotoxicity. J Pharmacol Exp Ther. 1984;230:742-748.
  • Holohan PD, Sokol PP, Ross CR, et al. Gentamicin-induced increases in cytosolic calcium in pig kidney cells (LLC-PK1). J Pharmacol Exp Ther. 1988;247:349-354.
  • Inui K, Saito H, Iwata T, Hori R. Aminoglycoside-induced alterations in apical membranes of kidney epithelial cell line (LLC-PK1). Am J Physiol. 1988;254:C251-C257.
  • Takano M, Okuda M, Yasuhara M, Hori R. Cellular toxicity of aminoglycoside antibiotics in G418-sensitive and -resistant LLC-PK1 cells. Pharm Res. 1994;11:609-615.
  • Scoble J E, Senior JCM, Chan P, Varghese Z, S wen y P, Moorhead J F. In vitro cyclospor in toxicity: the effect of verapamil. Transplantation. 1989;47:647-650.
  • Montine TJ, Borch RF. Quiescent LLC-PK1 cells as a model for cis-diamminedichloroplatinum(II) nephrotoxicity and modulation by thiol rescue agents.Cancer Res. 1988;48:6017-6024.
  • Inui K, Okano T, Takano M, Kitazawa S, Hori R. A simple method for the isolation of basolateral plasma membrane vesicles from rat kidney cortex. Biochim Biophys Act a. 1981;647:150-154.
  • Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
  • Dobyan DC, Levi J, Jacobs C, Kosek J, Weiner MW. Mechanism of cis-platinum nephrotoxicity: II. morphologic observations. J Pharmacol Exp Ther. 1980;213:551-556.
  • Jones BR, Bhalla RB, Mladek J, et al. Comparison of methods of evaluating nephrotoxicity of cis-platinum. Clin Pharmacol Ther. 1980;27:557-562.
  • Yamasaki F, Shinkawa T, Wa tana be M, Mizota M. Uptake of human urinary trypsin inhibitor by the kidney epithelial cell line, LLC-PK1. Eur J Physiol. 1996;433:9-15.
  • Yamasaki F, Ishibashi M, Nakakuki M, Watanabe M, Shinkawa T, Mizota M. Protective action of ulinastatin against cisplatin nephrotoxicity in mice and its effect on the lysosomal fragility. Nephron. 1996;74:158-167.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.